Skip to content
PeptideRank

Compare · all pairs

A

PT-141

B

Tirzepatide

A side-by-side look at what PT-141 and Tirzepatide actually are, so you can see where they overlap and where they genuinely differ before deciding which is worth researching further — no score, no “winner,” just the facts next to each other.

FDA status

PT-141

FDA-approved — Vyleesi, for premenopausal HSDD only (the compounded version this board ranks is not FDA-reviewed)

Tirzepatide

FDA-approved — Zepbound & Mounjaro (the compounded version this board ranks is not independently FDA-reviewed)

Typical dose / use

PT-141

Vyleesi's approved dose: 1.75 mg SC as needed, ≤8 doses/month (the compounded version has no agency-set dose)

Tirzepatide

2.5–15 mg/week (FDA label range)

Product forms

PT-141

Injectable — Vyleesi ships as a pre-filled autoinjector; the compounded version is a reconstituted powder vial

Tirzepatide

Injectable

How it works

PT-141

Activates melanocortin receptors — chiefly MC4R in the hypothalamus — believed to trigger dopamine release that increases sexual desire, a brain-mediated mechanism distinct from PDE5 inhibitors, which act on blood flow.

Tirzepatide

Activates two hormone receptors at once — GIP and GLP-1 — slowing gastric emptying, increasing insulin release when blood sugar is high, and reducing appetite.

Providers ranked on this board

PT-141

7

Tirzepatide

111

Cost on this board

PT-141

From $75/mo

Tirzepatide

From $79/mo

Every fact above is reused from PT-141's and Tirzepatide's own compound guides, not re-derived here. A highlighted value means that number is objectively larger or smaller — more providers ranked, a lower standing price — never a claim about which compound is “better.” Cost and provider counts are read live from each compound's own board and can change without notice.

Go deeper on each compound

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

This page is a fact comparison, not a recommendation for either compound — talk to a licensed clinician about your own situation.